Engineered Bacteriophage Control for Citrus Canker and Rice Blight

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for managing citrus canker and rice blight, caused by Xanthomonas pathogens, are inadequate, with copper-based controls stimulating mite populations and having environmental concerns, and existing bacteriophages lack specificity and controllability for field applications.

Innovation Solution

Development of novel filamentous bacteriophages, such as Cf and Cf2, which integrate into Xanthomonas genomes, are engineered to be recombinant and controllable, ensuring they only infect and kill bacterial cells once, preventing further spread and using coat protein engineering for stability and specificity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If copper-based products are used to control citrus canker, then disease control effectiveness is improved, but mite population growth is stimulated and environmental concerns arise

Engineering Contradiction:
Improvedisease control effectivenessVSAvoidmite population growth and environmental harm
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention uses bacteriophage proteins (phaseins) that specifically target and segment the function of bacterial type III secretion systems, preventing pathogen delivery of effector proteins without affecting other biological systems, thereby avoiding harmful side effects on mites and the environment

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs bacteriophage-derived pesticidal proteins as intermediaries that specifically bind to and inhibit bacterial type III secretion systems, providing disease control without the non-specific toxic effects of copper-based broad-spectrum antimicrobials

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If existing bacteriophages are used for field applications, then bacterial infection is inhibited, but lack of specificity and controllability limits their effectiveness

Engineering Contradiction:
Improvebacterial infection inhibitionVSAvoidspecificity and controllability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention modifies bacteriophage proteins to express pesticidal phaseins with specific functional properties localized to the protein structure, enabling targeted inhibition of type III secretion systems while maintaining specificity for particular bacterial pathogens through engineered coat protein recognition

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent engineers bacteriophages with modified parameters including specific coat protein sequences for targeted recognition, controlled expression levels of pesticidal proteins, and tuned stability characteristics to optimize field application performance and specificity

Inventive Principle:
Principle #35Parameter changes

3Reliability

If bacteriophages are engineered for stability and specificity, then field application effectiveness is improved, but engineering complexity increases

Engineering Contradiction:
Improvefield application effectivenessVSAvoidengineering complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention creates multi-functional bacteriophage constructs where single engineered proteins serve multiple purposes: structural coat functions, specific pathogen recognition, and pesticidal activity through type III secretion inhibition, reducing the need for separate engineering components

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These bacteriophages effectively inhibit Xanthomonas infections, reducing disease severity in citrus and rice crops, while being designed for safe, controlled use in agricultural settings, avoiding environmental harm and mite population issues.

Implementation Method 1

Bacteriophage (or called 'phage' in this application interchangeably) is a naturally occurring virus that that infects and replicates within bacteria. The replication of a bacteriophage may have a 'lytic cycle' or a 'lysogenic cycle'... With lytic phages, bacterial cells are broken open (lysed) and destroyed after immediate replication of the phage.

Methodology Applied
Scientific EffectViral replication and lysis:

Data Source

PatentUS10626375B2Disease control of the plant bacterial pathogens causing citrus canker and rice blight
Publication Date: 2020.04.21 AUXERGEN INC
  • US10626375B2 patent drawing
  • US10626375B2 patent drawing
  • US10626375B2 patent drawing

AI summary

The present invention describes applications and methods (1) to use bacterophage Cf and its variants to prevent and treat the citrus canker pathogen, Xanthomonas citri subsp. citri; (2) to engineer recombinant Cf phages that the infectivity is controllable without being harmful to the rest of environment; (3) to engineer and produce recombinant Cf phages with longer storage shelf life; (4) to use Cf phage as a vector for the introduction and insertion of foreign genetic material into Xanthomonas citri subsp. citri. genome; (5) to use and engineer Xp12 and Xf bacteriophages to inhibit Xanthomonas oryzae pv. oryzae, the causal agent of the rice blight disease.